이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Assessing Intratendinous Pressure and Its Correlation With Tendon Structure, Patient Characteristics, and Pain Symptoms in Individuals With and Without Midportion Achilles Tendinopathy

2026년 11월 2일 업데이트: University Hospital, Ghent

Assessing Intratendinous Pressure and Its Correlation With Tendon Structure, Patient Characteristics, and Pain Symptoms in Individuals With and Without Midportion Achilles Tendinopathy: An Observational Study

Study type: Observational study

Aim: To assess intratendinous pressure in individuals with and without midportion Achilles tendinopathy and investigate its correlation with tendon structure, patient characteristics, and pain symptoms.

Intervention: This is a non-interventional, observational study. Intratendinous pressure is measured using an invasive measurement method (e.g., Compass Universal Hg), used in accordance with its intended purpose.

Participants: Adults aged 18-55, both male and female, including patients with clinically diagnosed Achilles tendinopathy and healthy control participants.

Outcome measures:

  • Primary: Intratendinous pressure (mm Hg)

  • Secondary:

    • Tendon structure (e.g., tendon thickness, cross-sectional area (CSA) (cm2), tendon volume (cm3) determined on ultrasound and MRI)
    • Clinical outcomes (VISA-A, TENDINS-A)
    • Patient characteristics (e.g., activity level, BMI, symptom duration, age,..)

Discussion: The study seeks to better understand whether intratendinous pressure is increased in symptomatic Achilles tendons compared to healthy individuals. It also examines whether there is an association with structural tendon changes, a range of patient-related factors and the clinical symptoms experienced by the patient. The findings may help refine the pathophysiological understanding of Achilles tendinopathy and support the development of future treatment strategies.

연구 개요

상태

아직 모집하지 않음

상세 설명

Achilles tendinopathy is a debilitating injury that is common among athletes, especially those involved in running sports. Around 30% of all runners exhibit Achilles tendinopathy with an annual incidence of 7-9%. Despite its high prevalence, the underlying pathophysiological mechanisms of Achilles tendinopathy remain incompletely understood. An emerging concept is the potential role of impaired intratendinous pressure homeostasis in the onset and progression of tendinopathy. A substantial body of in vitro and in vivo research concerning intratendinous pressure has already been conducted by Dr. Lauren Pringels, yet important knowledge gaps remain.

This observational study aims to investigate whether intratendinous pressure differs between individuals with and without Achilles tendinopathy. A secondary aim is to explore whether the intratendinous pressure correlates with tendon structure, patient characteristics, and pain symptoms.

Participants will be divided into two groups: patients clinically diagnosed with midportion Achilles tendinopathy, and asymptomatic healthy controls. The study aims to include approximately 25-30 participants per group. Participants will be recruited through sports physicians, physiotherapists, social media and study advertisements. All participants will undergo a standardized evaluation consisting of questionnaires, intratendinous pressure measurement, clinical examination and imaging assessments.

Patient-reported outcome measures will include:

  • VISA-A (Victorian Institute of Sport Assessment - Achilles)
  • TENDINS-A (TENDINopathy Severity Assessment - Achilles)

Patient characteristics such as age, sex, height, weight, BMI, activity level, and symptom duration will be recorded.

Intratendinous pressure measurement will be performed using a simple, directly invasive measurement method (e.g., Compass Universal Hg), in accordance with its intended clinical use. The patient is positioned prone on the examination table, with the foot supported in 30° plantar flexion. In this position, the tension on the tendon is virtually zero, representing the resting condition. The invasive measurement method is introduced under ultrasound guidance and the pressure is determined at the center of the tendon. Needle positioning is done at a 30° angle, in a distal direction and parallel to the collagen fibrils, to minimize tissue trauma.

In patients with Achilles tendinopathy, intratendinous pressure is measured at the point where the tendon is most swollen. In asymptomatic individuals, intratendinous pressure is measured at a fixed point.

Imaging assessments include B-mode ultrasound and MRI scans to assess tendon structure, including tendon thickness, cross-sectional area and tendon volume.

연구 유형

관찰

등록 (추정된)

60

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 장소

      • Ghent, 벨기에, 9000
        • Department of rehabilitation sciences
        • 연락하다:

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인)

건강한 자원 봉사자를 받아들입니다

예

연구 대상 성별

모두

샘플링 방법

비확률 샘플

연구 인구

Participants will be recruited from the outpatient clinics of UZ Gent and on the UGent campus, as well as through local physiotherapy practices and orthopedic clinics in the surrounding region. Recruitment methods include distribution of flyers, social media posts and direct referrals from healthcare providers. The study population consists of adults aged 18-55 years, including individuals with clinically diagnosed midportion Achilles tendinopathy and asymptomatic healthy controls.

설명

Inclusion Criteria healthy controls:

  • Participation in sports that strain the Achilles tendon (recreational or competitive) at least once a week
  • Age: 18-55 y/o

Exclusion Criteria healthy controls:

  • History of Achilles tendinopathy/rupture/surgery or other ankle pathology (e.g., arthritis)
  • Current pain/stiffness in the Achilles tendon (VISA-A < 100)
  • Underlying systemic diseases (rheumatological disorders, e.g., SpA, psoriatic arthritis; hypercholesterolemia; endocrine disorders)
  • Current pregnancy
  • Use of (fluoro)quinolones in the last 2 years
  • Coagulation disorders
  • Contraindication MRI scan

Inclusion Criteria patients with achilles tendinopathy:

  • Participation in sports that strain the Achilles tendon (recreational or competitive) at least once a week
  • Age: 18-55 y/o
  • Duration of symptoms: > 6 weeks and < 3 years
  • Midportion Achilles tendinopathy (a + b + c must be met) (a: Pain from 2.5 cm proximal to the posterosuperior calcaneal edge ; b: Pain during exercise anamnestic/single leg hop test (VAS-HOP) ; c: Ultrasound hypoechoic zones OR power Doppler signal OR increased APD)

Exclusion Criteria patients with achilles tendinopathy:

  • History of Achilles tendon rupture/surgery or other ankle pathology (e.g., arthritis)
  • Combination of midportion + insertional tendinopathy
  • Underlying systemic diseases (rheumatological disorders, e.g., SpA, psoriatic arthritis; hypercholesterolemia; endocrine disorders)
  • Current pregnancy
  • Use of (fluoro)quinolones in the last 2 years ; corticosteroid injection/sclerotherapy/ESWT < 3 months ago
  • Coagulation disorders
  • Contraindication MRI scan

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 관찰 모델: CASE_CONTROL
  • 시간 관점: CROSS_SECTIONAL

코호트 및 개입

그룹/코호트
개입 / 치료
Healthy controls

Individuals without achilles tendinopathy

Intratendinous pressure measurement will be performed using a simple, directly invasive measurement method (e.g., Compass Universal Hg), in accordance with its intended clinical use. The patient is positioned prone on the examination table, with the foot supported in 30° plantar flexion. In this position, the tension on the tendon is virtually zero, representing the resting condition. The invasive measurement method is introduced under ultrasound guidance and the pressure is determined at the center of the tendon. Needle positioning is done at a 30° angle, in a distal direction and parallel to the collagen fibrils, to minimize tissue trauma.

Patients with achilles tendinopathy

Patients with midportion achilles tendinopathy

Intratendinous pressure measurement will be performed using a simple, directly invasive measurement method (e.g., Compass Universal Hg), in accordance with its intended clinical use. The patient is positioned prone on the examination table, with the foot supported in 30° plantar flexion. In this position, the tension on the tendon is virtually zero, representing the resting condition. The invasive measurement method is introduced under ultrasound guidance and the pressure is determined at the center of the tendon. Needle positioning is done at a 30° angle, in a distal direction and parallel to the collagen fibrils, to minimize tissue trauma.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Intratendinous pressure
기간: Single measurement at baseline

Intratendinous pressure in the achilles tendon (mm Hg)

Single measurement at baseline

2차 결과 측정

결과 측정
측정값 설명
기간
Patient reported outcome measures
기간: Single measurement at baseline

VISA-A (Victorian Institute of Sport Assessment - Achilles) questionnaire ; score from 0-100 (higher score is better with 100 = no dysfunction, no pain)

Single measurement at baseline
Patient reported outcome measures
기간: Single measurement at baseline

TENDINS-A (TENDINopathy Severity Assessment - Achilles) questionnaire ; score ranging from 0-100 (higher score is worse with 0 = no dysfunction, no pain)

Single measurement at baseline
Patient characteristics
기간: Recorded at baseline

Collection of demographic and clinical variables including: age in years

Recorded at baseline
Patient characteristics
기간: Recorded at baseline

Collection of demographic and clinical variables including: sex (M/V/X)

Recorded at baseline
Patient characteristics
기간: Recorded at baseline

Collection of demographic and clinical variables including: height in cm

Recorded at baseline
Patient characteristics
기간: Recorded at baseline

Collection of demographic and clinical variables including: weight in kg

Recorded at baseline
Patient characteristics
기간: Recorded at baseline

Collection of demographic and clinical variables including: weight and height will be combined to report BMI in kg/m²

Recorded at baseline
Patient characteristics
기간: Recorded at baseline

Collection of demographic and clinical variables including: profession

Recorded at baseline
Patient characteristics
기간: Recorded at baseline

Collection of demographic and clinical variables including: physical activity level (using a 6-point likert scale)

Recorded at baseline
Patient characteristics
기간: Recorded at baseline

Collection of demographic and clinical variables including: duration of symptoms in weeks

Recorded at baseline
Tendon structure
기간: Single measurement at baseline

Assessment of tendon characteristics using ultrasound including: tendon thickness (anteroposterior diameter in cm)

Single measurement at baseline
Tendon structure
기간: Single measurement at baseline

Assessment of tendon characteristics using ultrasound including: cross-sectional area (cm²)

Single measurement at baseline
Tendon structure
기간: Single measurement at baseline

Assessment of tendon characteristics using ultrasound including: vascularity (color and power doppler signal)

Single measurement at baseline
Tendon structure
기간: Single measurement at baseline

Assessment of tendon characteristics using ultrasound including: tendon thickening (= anteroposterior diameter at thickest part of the tendon (cm) - anteroposterior diameter at 2cm proximal from calcaneal notch (cm))

Single measurement at baseline
Tendon structure
기간: Single measurement at baseline

Assessment of tendon characteristics using MRI including: tendon volume (cm²)

Single measurement at baseline
Tendon structure
기간: Single measurement at baseline

Assessment of tendon characteristics using MRI including: T2/T2* mapping

Single measurement at baseline
Perfusion pressure
기간: Single measurement at baseline

Assessment of blood pressure to calculate perfusion pressure: ((diastolic pressure + 1/3 × [systolic pressure - diastolic pressure]) - intratendinous pressure)

Single measurement at baseline

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 10월 28일

기본 완료 (추정된)

2026년 12월 1일

연구 완료 (추정된)

2026년 12월 1일

연구 등록 날짜

최초 제출

2025년 11월 14일

QC 기준을 충족하는 최초 제출

2026년 11월 2일

처음 게시됨 (실제)

2026년 11월 9일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 9일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 2일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • ONZ-2025-0357

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다